ETF Holdings Breakdown of QGEN

Stock Name	Qiagen NV
Ticker	QGEN(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	NL0015001WM6
LEI	54930036WK3GMCN17Z57

News associated with QGEN

Blue Trust Inc. Acquires 3,157 Shares of QIAGEN N.V. (NYSE:QGEN): Blue Trust Inc. grew its holdings in QIAGEN N.V. (NYSE:QGEN – Free Report) by 30.5% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,519 shares of the company’s stock after acquiring an additional 3,157 shares during the period. Blue Trust Inc.’s holdings in […] - 2025-06-22 08:22:57
Qiagen (NYSE:QGEN) Shares Sold by Rhumbline Advisers: Rhumbline Advisers decreased its stake in Qiagen (NYSE:QGEN – Free Report) by 5.4% during the 1st quarter, HoldingsChannel reports. The firm owned 194,303 shares of the company’s stock after selling 11,088 shares during the period. Rhumbline Advisers’ holdings in Qiagen were worth $7,801,000 as of its most recent filing with the Securities and Exchange Commission. […] - 2025-06-11 08:54:44
Brokerages Set Qiagen (NYSE:QGEN) Target Price at $48.42: Qiagen (NYSE:QGEN – Get Free Report) has earned an average recommendation of “Hold” from the ten ratings firms that are covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokerages […] - 2025-06-11 05:22:44
Tidal Investments LLC Buys 7,815 Shares of Qiagen (NYSE:QGEN): Tidal Investments LLC grew its stake in Qiagen (NYSE:QGEN – Free Report) by 72.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,559 shares of the company’s stock after acquiring an additional 7,815 shares during the period. Tidal Investments […] - 2025-05-27 08:21:01
Qiagen (NYSE:QGEN) Holdings Lifted by Tower Research Capital LLC TRC: Tower Research Capital LLC TRC boosted its holdings in Qiagen (NYSE:QGEN – Free Report) by 770.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,490 shares of the company’s stock after acquiring an additional 2,204 shares during the quarter. Tower […] - 2025-05-09 08:55:01
Qiagen (NYSE:QGEN) Upgraded to “Strong-Buy” at StockNews.com: Qiagen (NYSE:QGEN – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Friday. QGEN has been the subject of several other reports. Baird R W cut Qiagen from a “strong-buy” rating to a “hold” rating in a research note on […] - 2025-05-09 07:56:48
Zacks Research Weighs in on Qiagen’s Q3 Earnings (NYSE:QGEN): Qiagen (NYSE:QGEN – Free Report) – Equities research analysts at Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for shares of Qiagen in a research report issued on Thursday, April 24th. Zacks Research analyst R. Department now expects that the company will earn $0.57 per share for the quarter, down from their […] - 2025-04-29 05:54:55
LPL Financial LLC Boosts Stake in Qiagen (NYSE:QGEN): LPL Financial LLC grew its holdings in Qiagen (NYSE:QGEN – Free Report) by 2.6% during the fourth quarter, HoldingsChannel reports. The firm owned 17,240 shares of the company’s stock after acquiring an additional 432 shares during the period. LPL Financial LLC’s holdings in Qiagen were worth $768,000 at the end of the most recent reporting […] - 2025-04-23 07:18:46
Brokerages Set Qiagen (NYSE:QGEN) Target Price at $47.71: Shares of Qiagen (NYSE:QGEN – Get Free Report) have received a consensus recommendation of “Hold” from the eleven research firms that are currently covering the firm, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month […] - 2025-04-22 05:35:00
QIAGEN Unveils QIAprep& Plasmodium Kit For Malaria Detection And Surveillance: (RTTNews) - QIAGEN N.V. (QGEN) has unveiled the QIAprep& Plasmodium Kit along with two companion assays to enhance efforts in malaria research and monitoring. This innovative solution streamlines sample preparation and quantitative PCR (qPCR) into a unified workflow, enabling fas - 2025-04-01 05:45:40
Qiagen (NYSE:QGEN) Receives $47.71 Average PT from Analysts: Shares of Qiagen (NYSE:QGEN – Get Free Report) have been assigned a consensus rating of “Hold” from the ten analysts that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month target price […] - 2025-03-03 06:32:49
QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology: (RTTNews) - QIAGEN N.V. (QGEN) announced that it has filed a complaint against bioMrieux S.A. for patent infringement, reinforcing its commitment to protecting the scientific advancements behind its proprietary QuantiFERON technology. - 2025-03-03 06:16:07
Qiagen (NYSE:QGEN) Stock Rating Lowered by Robert W. Baird: Qiagen (NYSE:QGEN – Get Free Report) was downgraded by Robert W. Baird from an “outperform” rating to a “neutral” rating in a research report issued to clients and investors on Wednesday, MarketBeat reports. They currently have a $42.00 price target on the stock, down from their prior price target of $52.00. Robert W. Baird’s price […] - 2025-02-21 08:42:50
Qiagen (NYSE:QGEN) Reaches New 1-Year Low Following Analyst Downgrade: Qiagen (NYSE:QGEN – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Monday after UBS Group lowered their price target on the stock from $50.00 to $48.00. UBS Group currently has a neutral rating on the stock. Qiagen traded as low as $39.63 and last traded at $39.97, with a […] - 2025-02-12 06:14:58

QGEN institutional holdings

The following institutional investment holdings of QGEN have been identified

Date ETF ISIN/Name Num Shares Book value
2025-06-23 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 1,670 USD 78,006

2025-06-23 IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc)) 4 USD 187

Total = 1,674 USD 78,193
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-23	IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF)	1,670	USD 78,006
2025-06-23	IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc))	4	USD 187
Total =	1,674	USD 78,193

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.